For Women

Clinical Trial Information

ContraMed is actively recruiting clinical study participants in a number of U.S. cities.   To learn more, please visit

Clinical Study Title:  Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception Identifier:  NCT02446821


CAUTION: New Drug- Limited by Federal Law to Investigational Use.